{"id":25112,"date":"2024-03-23T16:29:01","date_gmt":"2024-03-23T16:29:01","guid":{"rendered":"https:\/\/medgyd.lt\/cc\/human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba-1000-v-milteliai-ir-tirpiklis-injekciniam-ar-infuziniam-tirpalui-milteliai-tirpiklio-flakonas-20-ml-baxject-komplektas\/"},"modified":"2024-03-23T16:29:06","modified_gmt":"2024-03-23T16:29:06","slug":"human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba-1000-v-milteliai-ir-tirpiklis-injekciniam-ar-infuziniam-tirpalui-milteliai-tirpiklio-flakonas-20-ml-baxject-komplektas","status":"publish","type":"post","link":"https:\/\/medgyd.lt\/cc\/human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba-1000-v-milteliai-ir-tirpiklis-injekciniam-ar-infuziniam-tirpalui-milteliai-tirpiklio-flakonas-20-ml-baxject-komplektas\/","title":{"rendered":"Human coagulation factor VIII (inhibitor bypassing fraction) Baxalta [FEIBA] 1000 V milteliai ir tirpiklis injekciniam ar infuziniam tirpalui milteliai, tirpiklio flakonas (20 ml), BaxJect komplektas, vienkartin\u0117 adata, vienkartinis \u0161virk\u0161tas (20 ml), sparnuota &#8222;peteli\u0161k\u0117s&#8221; tipo adata, N1"},"content":{"rendered":"<h1>Detali informacija apie Human coagulation factor VIII (inhibitor bypassing fraction) Baxalta [FEIBA] 1000 V<\/h1>\n<p>&nbsp;<\/p>\n<p><strong>Veiklioji med\u017eiaga:<\/strong> VIII koaguliacijos faktoriaus antiinhibitoriaus-koagulianto kompleksas<\/p>\n<p><strong>Veikliosios med\u017eiagos koncentracija:<\/strong> 1000 V<\/p>\n<p><strong>Vartojimo b\u016bdas:<\/strong> leisti \u012f ven\u0105<\/p>\n<p><strong>Vaistinio preparato grup\u0117:<\/strong> Vaistinis preparatas<\/p>\n<p><strong>Kitos vaisto dozuot\u0117s: <\/strong>milteliai, tirpiklio flakonas (20 ml), BaxJect komplektas, vienkartin\u0117 adata, vienkartinis \u0161virk\u0161tas (20 ml), sparnuota &#8222;peteli\u0161k\u0117s&#8221; tipo adata, N1, milteliai, flakonas tirpiklio (20 ml), filtravimo adata, perpylimo adata, aeracijos adata, vienkartin\u0117 adata, vienkartinis \u0161virk\u0161tas (20 ml), sparnuota &#8222;peteli\u0161k\u0117s&#8221; tipo adata, N1<strong><br \/>\n<\/strong><\/p>\n<p><strong>Vaistinio preparato pogrupis:<\/strong> Biologinis<\/p>\n<p><strong>Recepto poreikis:<\/strong> Receptinis<\/p>\n<p><strong>Preparato ATC kodas:<\/strong> B02BD03<\/p>\n<p><strong>Pakuot\u0117s tipas:<\/strong> flakonas<\/p>\n<p><strong>Dozuot\u0117 pakuot\u0117je:<\/strong> milteliai, tirpiklio flakonas (20 ml), BaxJect komplektas, vienkartin\u0117 adata, vienkartinis \u0161virk\u0161tas (20 ml), sparnuota &#8222;peteli\u0161k\u0117s&#8221; tipo adata, N1<\/p>\n<p><strong>Vaisto stadija:<\/strong> Perregistruotas 1996-02-15 LT\/1\/96\/1046\/003<\/p>\n<p><strong>Registruotojas: <\/strong>Baxalta Innovations GmbH.<\/p>\n<p><strong>Perregistravimo data: <\/strong>2008-03-06<\/p>\n<p><strong>Registracijos \u0161alis: <\/strong>Austrija<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Human coagulation factor VIII (inhibitor bypassing fraction) Baxalta [FEIBA] sud\u0117tyje yra: VIII koaguliacijos faktoriaus antiinhibitoriaus-koagulianto kompleksas &#8211; 1000 V milteliai ir tirpiklis injekciniam ar infuziniam tirpalui. Preparatas skirtas vartoti leisti \u012f ven\u0105. Receptinis preparatas. Pakuot\u0119 sudaro milteliai, tirpiklio flakonas (20 ml), BaxJect komplektas, vienkartin\u0117 adata, vienkartinis \u0161virk\u0161tas (20 ml), sparnuota &#8222;peteli\u0161k\u0117s&#8221; tipo adata, N1, milteliai, flakonas tirpiklio (20 ml), filtravimo adata, perpylimo adata, aeracijos adata, vienkartin\u0117 adata, vienkartinis \u0161virk\u0161tas (20 ml), sparnuota &#8222;peteli\u0161k\u0117s&#8221; tipo adata, N1 flakonas<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,2608,2612,4,5],"tags":[186,2610,1246,119,2611],"class_list":["post-25112","post","type-post","status-publish","format-standard","hentry","category-biologinis","category-human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba","category-human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba-1000-v","category-vaistai","category-vaistinis-preparatas-vaistai","tag-biologinis","tag-human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba","tag-milteliai-ir-tirpiklis-injekciniam-ar-infuziniam-tirpalui","tag-receptinis","tag-viii-koaguliacijos-faktoriaus-antiinhibitoriaus-koagulianto-kompleksas"],"_links":{"self":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/25112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/comments?post=25112"}],"version-history":[{"count":2,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/25112\/revisions"}],"predecessor-version":[{"id":46585,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/25112\/revisions\/46585"}],"wp:attachment":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/media?parent=25112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/categories?post=25112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/tags?post=25112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}